The industry is now poised to exploit the full therapeutic potential of these vehicles for emerging payloads and extrahepatic delivery.

Weiner, Ph.D., have described a next-generation vaccination technology that combines plasmid DNA with a lipid nanoparticle (LNP) delivery system. The research was conducted in collaboration with ...

2023 is set to be a landmark year for lipid-based delivery technology development and the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit returns to unite 140+ biopharma thought ...